Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
VMF
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Weekly News Recap #Phispers
1. 3-(1-biphenyl-4-ylmethyl-3-ethoxycarbonyl-1-butylcarbamoyl)propionate-3'-methyl-2'-(pentanoyl(2'-(tetrazol-5-ylate)biphenyl-4'-ylmethyl)amino)butyrate
2. Lcz 696
3. Lcz-696
4. Lcz696
5. Sacubitril And Valsartan Drug Combination
6. Sacubitril And Valsartan Sodium Anhydrous Drug Combination
7. Sacubitril And Valsartan Sodium Hydrate Drug Combination
8. Sacubitril Valsartan Drug Combination
9. Sacubitril Valsartan Sodium Anhydrous
10. Sacubitril Valsartan Sodium Hydrate
11. Sacubitril-valsartan
12. Sacubitril-valsartan Sodium Anhydrous Drug Combination
13. Sacubitril-valsartan Sodium Hydrate Drug Combination
14. Trisodium (3-(1-biphenyl-4-ylmethyl-3-ethoxycarbonyl-1-butylcarbamoyl)propionate-3'-methyl-2'-(pentanoyl(2'-(tetrazol-5-ylate)biphenyl-4'-ylmethyl)amino)butyrate) Hemipentahydrate
1. Sacubitril Valsartan Sodium Hydrate
2. Sacubitril Mixture With Valsartan
3. Wb8ft61183
4. Lcz 696
5. Sacubitril Valsartan Sodium Hydrate (jan)
6. Sacubitril Valsartan Sodium Hydrate [jan]
7. Entresto (tn)
8. Unii-wb8ft61183
9. Valsartan Mixture With Ahu-377
10. Ex-a2849
11. Mfcd29477717
12. 3-(1-biphenyl-4-ylmethyl-3-ethoxycarbonyl-1-butylcarbamoyl)propionate-3'-methyl-2'-(pentanoyl(2'-(tetrazol-5-ylate)biphenyl-4'-ylmethyl)amino)butyrate
13. Ac-29037
14. Sucabitril Valsartan Sodium Hydrate
15. Trisodium (3-(1-biphenyl-4-ylmethyl-3-ethoxycarbonyl-1-butylcarbamoyl)propionate-3'-methyl-2'-(pentanoyl(2'-(tetrazol-5-ylate)biphenyl-4'-ylmethyl)amino)butyrate) Hemipentahydrate
16. D10226
17. Valsartan Ahu-377 Sodium Hemipentahydrate
18. Q27292546
19. L-valine, N-(1-oxopentyl)-n-((2'-(2h-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-, Compd. With .alpha.-ethyl (.alpha.r,.gamma.s)-.gamma.-((3-carboxy-1-oxopropyl)amino)-.alpha.-methyl(1,1'-biphenyl)-4-pentanoate, Sodium Salt, Hydrate (2:2:6:5)
20. L-valine, N-(1-oxopentyl)-n-((2'-(2h-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-, Compd. With Alpha-ethyl(alphar,gammas)-gamma-((3-carboxy-1-oxopropyl)amino)-alpha-methyl(1,1'-biphenyl)-4-pentanoate, Sodium Salt, Hydrate (2:2:6:5)
Molecular Weight | 1916.0 g/mol |
---|---|
Molecular Formula | C96H120N12Na6O21 |
Hydrogen Bond Donor Count | 7 |
Hydrogen Bond Acceptor Count | 29 |
Rotatable Bond Count | 40 |
Exact Mass | 1915.8110694 g/mol |
Monoisotopic Mass | 1914.8077146 g/mol |
Topological Polar Surface Area | 396 Ų |
Heavy Atom Count | 135 |
Formal Charge | 0 |
Complexity | 1140 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 6 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 15 |
Entresto is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction.
Angiotensin Receptor Antagonists
Agents that antagonize ANGIOTENSIN RECEPTORS. Many drugs in this class specifically target the ANGIOTENSIN TYPE 1 RECEPTOR. (See all compounds classified as Angiotensin Receptor Antagonists.)
C09DX04
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : Reviewed
Rev. Date : 2017-12-22
Pay. Date : 2017-11-08
DMF Number : 31574
Submission : 2017-08-29
Status : Active
Type : II
Date of Issue : 2022-07-28
Valid Till : 2025-11-30
Written Confirmation Number : WC-0390
Address of the Firm :
Registrant Name : Pami Future Co., Ltd.
Registration Date : 2024-07-15
Registration Number : No. 583-30-ND(A)
Manufacturer Name : Dr. Reddy\'s Laboratories Limited@Dr. Reddy\'s Laboratories Limited
Manufacturer Address : CTO-SEZ Process Unit-01, Sector No.\'s 28 to 34, 36 to 37, 40, 50 to 53 & 03, Survey No.\'s 57 to 58, 60, 72 to 73, 76 to 77 & 80, Devunipalavalasa Village, Ranasthalam Mandal, Srikakulam District 532409, Andhra Pradesh, India@CTO Unit-VI, APIIC Industrial Estate, Pydibhimavaram Village, Ranasthalam Mandal, Srikakulam District, Andhra Pradesh - 532 409, India
Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.
GDUFA
DMF Review : Reviewed
Rev. Date : 2018-09-04
Pay. Date : 2017-12-20
DMF Number : 32337
Submission : 2017-12-21
Status : Active
Type : II
Available Reg Filing : ASMF |
Faran Shimi: Leading producer of high-quality APIs & alkaloid opiates, serving major pharmaceutical companies across the Middle East.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 37994
Submission : 2023-03-09
Status : Active
Type : II
Date of Issue : 2022-08-11
Valid Till : 2025-06-26
Written Confirmation Number : WC-0054
Address of the Firm :
Octavius has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.
GDUFA
DMF Review : Reviewed
Rev. Date : 2021-11-09
Pay. Date : 2021-09-20
DMF Number : 35868
Submission : 2021-04-28
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39382
Submission : 2024-01-27
Status : Active
Type : II
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Global Sales Information
Market Place
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?